78 related articles for article (PubMed ID: 31230228)
1. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy.
Jang JY; Oh D; Noh JM; Sun JM; Kim HK; Shim YM
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1167-1176. PubMed ID: 38613258
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy.
Hirohata R; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Ohsawa M; Kitasaki N; Okada M
World J Surg; 2024 May; ():. PubMed ID: 38757868
[TBL] [Abstract][Full Text] [Related]
3. Role of barium esophagography in patients with locally advanced esophageal cancer: evaluation of response to neoadjuvant chemoradiotherapy.
Tsurumaru D; Hiraka K; Komori M; Shioyama Y; Morita M; Honda H
Radiol Res Pract; 2013; 2013():502690. PubMed ID: 24369500
[TBL] [Abstract][Full Text] [Related]
4. Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis.
Zhu Y; Chen J; Sun X; Lou Y; Fang M; Zhou F; Zhang L; Xin Y
Front Oncol; 2023; 13():1177557. PubMed ID: 37228495
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
Gebauer F; Plum PS; Damanakis A; Chon SH; Popp F; Zander T; Quaas A; Fuchs H; Schmidt T; Schröder W; Bruns CJ
Ann Surg Oncol; 2023 Nov; 30(12):7422-7433. PubMed ID: 37210683
[TBL] [Abstract][Full Text] [Related]
6. Multimodal treatments for resectable esophagogastric junction cancer: A Bayesian network meta-analysis.
Shao P; Nima S; Tse Y; Suolang Z; Pubu C
Langenbecks Arch Surg; 2023 Mar; 408(1):123. PubMed ID: 36934163
[TBL] [Abstract][Full Text] [Related]
7. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.
Kitagawa Y; Ishihara R; Ishikawa H; Ito Y; Oyama T; Oyama T; Kato K; Kato H; Kawakubo H; Kawachi H; Kuribayashi S; Kono K; Kojima T; Takeuchi H; Tsushima T; Toh Y; Nemoto K; Booka E; Makino T; Matsuda S; Matsubara H; Mano M; Minashi K; Miyazaki T; Muto M; Yamaji T; Yamatsuji T; Yoshida M
Esophagus; 2023 Jul; 20(3):343-372. PubMed ID: 36933136
[No Abstract] [Full Text] [Related]
8. Advances in Treatment Models of Advanced Gastric Cancer.
Li T; He Y; Zhong Q; Yu J; Chen X
Technol Cancer Res Treat; 2022; 21():15330338221090353. PubMed ID: 36780331
[TBL] [Abstract][Full Text] [Related]
9. Comparison of treatment strategies and survival of early-onset gastric cancer: a population-based study.
Zhang C; Tang R; Zhu H; Ge X; Wang Y; Wang X; Miao L
Sci Rep; 2022 Apr; 12(1):6288. PubMed ID: 35428811
[TBL] [Abstract][Full Text] [Related]
10. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives.
Charalampakis N; Tsakatikas S; Schizas D; Kykalos S; Tolia M; Fioretzaki R; Papageorgiou G; Katsaros I; Abdelhakeem AAF; Sewastjanow-Silva M; Rogers JE; Ajani JA
World J Gastrointest Oncol; 2022 Jan; 14(1):181-202. PubMed ID: 35116110
[TBL] [Abstract][Full Text] [Related]
11. Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma.
Vos EL; Carr RA; Hsu M; Nakauchi M; Nobel T; Russo A; Barbetta A; Tan KS; Tang L; Ilson D; Ku GY; Wu AJ; Janjigian YY; Yoon SS; Bains MS; Jones DR; Coit D; Molena D; Strong VE
Br J Surg; 2021 Nov; 108(11):1332-1340. PubMed ID: 34476473
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Sensitivity and Efficacy of Clinical Chemotherapy Using Larval Zebrafish Patient-Derived Xenografts of Gastric Cancer.
Zhai J; Wu J; Wang Y; Fan R; Xie G; Wu F; He Y; Qian S; Tan A; Yao X; He M; Shen L
Front Cell Dev Biol; 2021; 9():680491. PubMed ID: 34164399
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Therapy Regimen Influences the Incidence and Implication of Nodal Downstaging in Patients with Gastric Cancer.
Stark AP; Blum MM; Chiang YJ; Das P; Minsky BD; Estrella JS; Ajani JA; Badgwell BD; Mansfield P; Ikoma N
J Gastric Cancer; 2020 Sep; 20(3):313-327. PubMed ID: 33024587
[TBL] [Abstract][Full Text] [Related]
14. Survival after neoadjuvant approaches to gastroesophageal junction cancer.
Xiang M; Chang DT; Heestand GM; Pollom EL
Gastric Cancer; 2020 Jan; 23(1):175-183. PubMed ID: 31230228
[TBL] [Abstract][Full Text] [Related]
15. No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.
Tsai C; Mueller A; Maubach J; Warschkow R; Nussbaum DP; Schmied BM; Blazer D; Gloor B; Worni M
Dig Surg; 2020; 37(3):249-257. PubMed ID: 31340206
[TBL] [Abstract][Full Text] [Related]
16. Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival.
Goense L; van der Sluis PC; van Rossum PSN; van der Horst S; Meijer GJ; Haj Mohammad N; van Vulpen M; Mook S; Ruurda JP; van Hillegersberg R
J Surg Oncol; 2017 Jun; 115(7):812-820. PubMed ID: 28267212
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis.
Li J; Zhao Q; Ge X; Song Y; Tian Y; Wang S; Liu M; Qiao X
BMC Surg; 2021 Mar; 21(1):137. PubMed ID: 33731072
[TBL] [Abstract][Full Text] [Related]
18. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K;
Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671
[TBL] [Abstract][Full Text] [Related]
19. Unanswered questions in the management of gastroesophageal junction adenocarcinoma: an overview from the medical oncologist's perspective.
Shah MA
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714486
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
